Genvax Technologies Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 11

Genvax Technologies General Information

Description

Developer of animal vaccines designed to accelerate treatments for the animal health industry. The company's saRNA platform allows for the rapid development of herd or flock-specific vaccines matched to the variant strain circulating in an animal-production operation by inserting a specific transgene or gene of interest matched to the variant strain into the platform, providing clients from the animal health industry with novel vaccines for the prevention and treatment of animal diseases.

Contact Information

Website
www.genvax.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2503 South Loop Drive
  • Suite 5446
  • Ames, IA 50010
  • United States
+1 (515)
Primary Industry
Other Agriculture
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 2503 South Loop Drive
  • Suite 5446
  • Ames, IA 50010
  • United States
+1 (515)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genvax Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 03-Feb-2025 Completed Clinical Trials - General
2. Seed Round 09-Aug-2022 Completed Clinical Trials - General
1. Grant 18-Apr-2022 $145K Completed Clinical Trials - General
To view Genvax Technologies’s complete valuation and funding history, request access »

Genvax Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed
To view Genvax Technologies’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Genvax Technologies Patents

Genvax Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260124157-A1 Methods of self-amplifying rna-lipid nanoparticle manufacture and compositions derived therefrom Pending 09-Aug-2024
WO-2026033498-A1 Methods of self-amplifying rna-lipid nanoparticle manufacture and compositions derived therefrom Pending 09-Aug-2024

Genvax Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genvax Technologies Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
1945 Capital Family Office Minority
Grit Road Partners Venture Capital Minority
InnoVenture Iowa Venture Capital Minority
Next Level Ventures Venture Capital Minority
Ag Startup Engine Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Genvax Technologies FAQs

  • When was Genvax Technologies founded?

    Genvax Technologies was founded in 2021.

  • Where is Genvax Technologies headquartered?

    Genvax Technologies is headquartered in Ames, IA.

  • What is the size of Genvax Technologies?

    Genvax Technologies has 9 total employees.

  • What industry is Genvax Technologies in?

    Genvax Technologies’s primary industry is Other Agriculture.

  • Is Genvax Technologies a private or public company?

    Genvax Technologies is a Private company.

  • What is Genvax Technologies’s current revenue?

    The current revenue for Genvax Technologies is .

  • How much funding has Genvax Technologies raised over time?

    Genvax Technologies has raised $8.4M.

  • Who are Genvax Technologies’s investors?

    1945 Capital, Grit Road Partners, InnoVenture Iowa, Next Level Ventures, and Ag Startup Engine are 5 of 11 investors who have invested in Genvax Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process